ANAPTYSBIO INC's ticker is ANAB and the CUSIP is 032724106. A total of 124 filers reported holding ANAPTYSBIO INC in Q2 2021. The put-call ratio across all filers is 1.70 and the average weighting 0.2%.
Links
Filings
- All filings
- Annual reports (20-F)
- Quarterly reports (6-K)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $48,000 | +54.8% | 2,643 | +77.5% | 0.00% | – |
| Q2 2023 | $31,000 | +24.0% | 1,489 | +30.4% | 0.00% | – |
| Q1 2023 | $25,000 | -64.8% | 1,142 | -50.1% | 0.00% | – |
| Q4 2022 | $71,000 | +208.7% | 2,290 | +146.0% | 0.00% | – |
| Q3 2022 | $23,000 | +43.8% | 931 | +16.2% | 0.00% | – |
| Q2 2022 | $16,000 | -97.7% | 801 | -97.1% | 0.00% | – |
| Q1 2022 | $689,000 | -50.5% | 27,855 | -30.5% | 0.00% | – |
| Q4 2021 | $1,392,000 | +36.1% | 40,066 | +6.2% | 0.00% | – |
| Q3 2021 | $1,023,000 | +4.5% | 37,724 | -0.1% | 0.00% | – |
| Q2 2021 | $979,000 | +4795.0% | 37,777 | +3944.6% | 0.00% | – |
| Q1 2021 | $20,000 | – | 934 | +31033.3% | 0.00% | – |
| Q3 2020 | $0 | -100.0% | 3 | -93.5% | 0.00% | – |
| Q2 2020 | $1,000 | -50.0% | 46 | -68.5% | 0.00% | – |
| Q1 2020 | $2,000 | -93.8% | 146 | -92.4% | 0.00% | – |
| Q4 2019 | $32,000 | -69.2% | 1,928 | -35.1% | 0.00% | – |
| Q3 2019 | $104,000 | -26.2% | 2,973 | +18.5% | 0.00% | – |
| Q2 2019 | $141,000 | -16.6% | 2,508 | +8.6% | 0.00% | – |
| Q1 2019 | $169,000 | +50.9% | 2,309 | +31.3% | 0.00% | – |
| Q4 2018 | $112,000 | -70.3% | 1,758 | -53.5% | 0.00% | – |
| Q3 2018 | $377,000 | -92.1% | 3,780 | -94.4% | 0.00% | -100.0% |
| Q2 2018 | $4,754,000 | +14.6% | 66,906 | +67.8% | 0.00% | 0.0% |
| Q1 2018 | $4,150,000 | +1387.5% | 39,877 | +1342.2% | 0.00% | – |
| Q4 2017 | $279,000 | +389.5% | 2,765 | +68.7% | 0.00% | – |
| Q3 2017 | $57,000 | +5600.0% | 1,639 | +2826.8% | 0.00% | – |
| Q2 2017 | $1,000 | -87.5% | 56 | -81.3% | 0.00% | – |
| Q1 2017 | $8,000 | – | 300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FRAZIER MANAGEMENT LLC | 3,688,448 | $102,354,000 | 54.68% |
| Novo Holdings A/S | 3,033,504 | $84,180,000 | 8.96% |
| BVF INC/IL | 1,738,600 | $48,246,000 | 8.21% |
| Cormorant Asset Management, LP | 895,626 | $24,854,000 | 3.61% |
| Perceptive Advisors | 881,957 | $24,474,000 | 1.39% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 100,500 | $2,789,000 | 1.07% |
| ACUTA CAPITAL PARTNERS, LLC | 165,690 | $4,138,000 | 0.98% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 845,746 | $23,469,000 | 0.90% |
| Iguana Healthcare Management, LLC | 50,000 | $1,388,000 | 0.69% |
| Boxer Capital, LLC | 50,000 | $1,388,000 | 0.30% |